Evidence map›Paper›PMID 27063107›Full record

ReviewNature reviews. Neurology2016

Neuropsychiatric sequelae of stroke.

José M Ferro, Lara Caeiro, Maria Luísa Figueira

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 102 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 3 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06429384 phase2completednot on this mapstarted 2023, after this paper: background citation

Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial -- Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Trial

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2023Enrolled240ConditionsAcute Ischemic StrokeArmsY-3 Injection/Y-3 blank injection
NCT06517173 phase3completednot on this mapstarted 2024, after this paper: background citation

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Y-3 in Chinese Subjects With Acute Ischemic Stroke

TypeinterventionalSponsorBeijing Tiantan HospitalRan2024 to 2025Enrolled998ConditionsAcute Ischemic StrokeArmsY-3 for injection, Placebo control group
3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 3 syntheses or guidelines pooled it, 221 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Poststroke psychosis: a systematic review.Journal of neurology, neurosurgery, and psychiatry · 2018
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Reshaping life after stroke: a grounded theory.International journal of nursing studies advances · 2025
    Article
  16. Biology · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

José M FerroDepartment of Neurosciences, Centro Hospitalar Lisboa Norte, University of Lisbon, Professor Egas Moniz Avenue, 1649-035 Lisbon, Portugal.
Lara CaeiroInstituto de Medicina Molecular, University of Lisbon, Professor Egas Moniz Avenue, 1649-028 Lisbon, Portugal.
Maria Luísa FigueiraDepartment of Neurosciences, Centro Hospitalar Lisboa Norte, University of Lisbon, Professor Egas Moniz Avenue, 1649-035 Lisbon, Portugal.
University of Lisbon · PTCentro Hospitalar Lisboa Norte · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke survivors are often affected by psychological distress and neuropsychiatric disturbances. About one-third of stroke survivors experience depression, anxiety or apathy, which are the most common neuropsychiatric sequelae of stroke. Neuropsychiatric sequelae are disabling, and can have a negative influence on recovery, reduce quality of life and lead to exhaustion of the caregiver. Despite the availability of screening instruments and effective treatments, neuropsychiatric disturbances attributed to stroke are currently underdiagnosed and undertreated. Stroke severity, stroke-related disabilities, cerebral small vessel disease, previous psychiatric disease, poor coping strategies and unfavourable psychosocial environment influence the presence and severity of the psychiatric sequelae of stroke. Although consistent associations between psychiatric disturbances and specific stroke locations have yet to be confirmed, functional MRI studies are beginning to unveil the anatomical networks that are disrupted in stroke-associated psychiatric disorders. Evidence regarding biochemical and genetic biomarkers for stroke-associated psychiatric disorders is still limited, and better understanding of the biological determinants and pathophysiology of these disorders is needed. Investigation into the management of these conditions must be continued, and should include pilot studies to assess the benefits of innovative behavioural interventions and large-scale cooperative randomized controlled pharmacological trials of drugs that are safe to use in patients with stroke.

Indexed as

Anxiety DisordersDepressive DisorderPersonality DisordersStress Disorders, Post-TraumaticStrokeSurvivorsApathyHumans

Identifiers

PMID27063107
OpenAlexW2318998344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.